vs

Side-by-side financial comparison of agilon health, inc. (AGL) and MYR GROUP INC. (MYRG). Click either name above to swap in a different company.

agilon health, inc. is the larger business by last-quarter revenue ($1.6B vs $973.5M, roughly 1.6× MYR GROUP INC.). MYR GROUP INC. runs the higher net margin — 3.8% vs -12.0%, a 15.8% gap on every dollar of revenue. On growth, MYR GROUP INC. posted the faster year-over-year revenue change (17.3% vs 3.1%). MYR GROUP INC. produced more free cash flow last quarter ($84.9M vs $-23.5M). Over the past eight quarters, MYR GROUP INC.'s revenue compounded faster (9.3% CAGR vs -1.1%).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

MYR Group Inc. is an American corporation that offers electrical construction services for transmission and distribution lines, substations, commercial and industrial buildings, and renewable energy. It is the parent company to 12 subsidiary electrical construction companies.

AGL vs MYRG — Head-to-Head

Bigger by revenue
AGL
AGL
1.6× larger
AGL
$1.6B
$973.5M
MYRG
Growing faster (revenue YoY)
MYRG
MYRG
+14.2% gap
MYRG
17.3%
3.1%
AGL
Higher net margin
MYRG
MYRG
15.8% more per $
MYRG
3.8%
-12.0%
AGL
More free cash flow
MYRG
MYRG
$108.4M more FCF
MYRG
$84.9M
$-23.5M
AGL
Faster 2-yr revenue CAGR
MYRG
MYRG
Annualised
MYRG
9.3%
-1.1%
AGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGL
AGL
MYRG
MYRG
Revenue
$1.6B
$973.5M
Net Profit
$-188.9M
$36.5M
Gross Margin
11.4%
Operating Margin
-12.3%
4.8%
Net Margin
-12.0%
3.8%
Revenue YoY
3.1%
17.3%
Net Profit YoY
-78.5%
129.1%
EPS (diluted)
$2.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
MYRG
MYRG
Q4 25
$1.6B
$973.5M
Q3 25
$1.4B
$950.4M
Q2 25
$1.4B
$900.3M
Q1 25
$1.5B
$833.6M
Q4 24
$1.5B
$829.8M
Q3 24
$1.5B
$888.0M
Q2 24
$1.5B
$828.9M
Q1 24
$1.6B
$815.6M
Net Profit
AGL
AGL
MYRG
MYRG
Q4 25
$-188.9M
$36.5M
Q3 25
$-110.2M
$32.1M
Q2 25
$-104.4M
$26.5M
Q1 25
$12.1M
$23.3M
Q4 24
$-105.8M
$16.0M
Q3 24
$-117.6M
$10.6M
Q2 24
$-30.7M
$-15.3M
Q1 24
$-6.1M
$18.9M
Gross Margin
AGL
AGL
MYRG
MYRG
Q4 25
11.4%
Q3 25
11.8%
Q2 25
11.5%
Q1 25
11.6%
Q4 24
10.4%
Q3 24
8.7%
Q2 24
4.9%
Q1 24
10.6%
Operating Margin
AGL
AGL
MYRG
MYRG
Q4 25
-12.3%
4.8%
Q3 25
-9.1%
4.9%
Q2 25
-8.3%
4.4%
Q1 25
-1.4%
4.1%
Q4 24
-7.1%
3.6%
Q3 24
-9.2%
2.3%
Q2 24
-2.9%
-2.5%
Q1 24
-0.4%
3.0%
Net Margin
AGL
AGL
MYRG
MYRG
Q4 25
-12.0%
3.8%
Q3 25
-7.7%
3.4%
Q2 25
-7.5%
2.9%
Q1 25
0.8%
2.8%
Q4 24
-6.9%
1.9%
Q3 24
-8.1%
1.2%
Q2 24
-2.1%
-1.8%
Q1 24
-0.4%
2.3%
EPS (diluted)
AGL
AGL
MYRG
MYRG
Q4 25
$2.33
Q3 25
$2.05
Q2 25
$1.70
Q1 25
$1.45
Q4 24
$0.97
Q3 24
$0.65
Q2 24
$-0.91
Q1 24
$1.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
MYRG
MYRG
Cash + ST InvestmentsLiquidity on hand
$173.7M
$150.2M
Total DebtLower is stronger
$35.0M
$59.0M
Stockholders' EquityBook value
$126.7M
$660.4M
Total Assets
$1.3B
$1.6B
Debt / EquityLower = less leverage
0.28×
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
MYRG
MYRG
Q4 25
$173.7M
$150.2M
Q3 25
$171.7M
$76.2M
Q2 25
$171.4M
$23.0M
Q1 25
$136.9M
$10.9M
Q4 24
$188.2M
$3.5M
Q3 24
$148.2M
$7.6M
Q2 24
$109.5M
$1.9M
Q1 24
$111.7M
$3.9M
Total Debt
AGL
AGL
MYRG
MYRG
Q4 25
$35.0M
$59.0M
Q3 25
$72.0M
Q2 25
$86.1M
Q1 25
$87.2M
Q4 24
$74.4M
Q3 24
$93.2M
Q2 24
$45.1M
Q1 24
$37.9M
Stockholders' Equity
AGL
AGL
MYRG
MYRG
Q4 25
$126.7M
$660.4M
Q3 25
$306.1M
$617.6M
Q2 25
$408.9M
$583.2M
Q1 25
$500.3M
$548.7M
Q4 24
$471.0M
$600.4M
Q3 24
$574.9M
$588.5M
Q2 24
$676.6M
$633.3M
Q1 24
$689.3M
$663.7M
Total Assets
AGL
AGL
MYRG
MYRG
Q4 25
$1.3B
$1.6B
Q3 25
$1.6B
$1.6B
Q2 25
$1.7B
$1.6B
Q1 25
$1.9B
$1.5B
Q4 24
$1.7B
$1.6B
Q3 24
$2.1B
$1.6B
Q2 24
$2.2B
$1.6B
Q1 24
$2.3B
$1.6B
Debt / Equity
AGL
AGL
MYRG
MYRG
Q4 25
0.28×
0.09×
Q3 25
0.12×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.12×
Q3 24
0.16×
Q2 24
0.07×
Q1 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
MYRG
MYRG
Operating Cash FlowLast quarter
$-20.5M
$114.8M
Free Cash FlowOCF − Capex
$-23.5M
$84.9M
FCF MarginFCF / Revenue
-1.5%
8.7%
Capex IntensityCapex / Revenue
0.2%
3.1%
Cash ConversionOCF / Net Profit
3.14×
TTM Free Cash FlowTrailing 4 quarters
$-119.0M
$232.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
MYRG
MYRG
Q4 25
$-20.5M
$114.8M
Q3 25
$-18.2M
$95.6M
Q2 25
$-35.1M
$32.9M
Q1 25
$-32.0M
$83.3M
Q4 24
$16.4M
$21.1M
Q3 24
$-7.7M
$35.6M
Q2 24
$-18.7M
$22.7M
Q1 24
$-47.8M
$7.7M
Free Cash Flow
AGL
AGL
MYRG
MYRG
Q4 25
$-23.5M
$84.9M
Q3 25
$-21.3M
$65.4M
Q2 25
$-38.3M
$11.6M
Q1 25
$-35.8M
$70.2M
Q4 24
$13.2M
$8.8M
Q3 24
$-11.2M
$18.0M
Q2 24
$-22.0M
$2.5M
Q1 24
$-50.9M
$-18.1M
FCF Margin
AGL
AGL
MYRG
MYRG
Q4 25
-1.5%
8.7%
Q3 25
-1.5%
6.9%
Q2 25
-2.7%
1.3%
Q1 25
-2.3%
8.4%
Q4 24
0.9%
1.1%
Q3 24
-0.8%
2.0%
Q2 24
-1.5%
0.3%
Q1 24
-3.2%
-2.2%
Capex Intensity
AGL
AGL
MYRG
MYRG
Q4 25
0.2%
3.1%
Q3 25
0.2%
3.2%
Q2 25
0.2%
2.4%
Q1 25
0.3%
1.6%
Q4 24
0.2%
1.5%
Q3 24
0.2%
2.0%
Q2 24
0.2%
2.4%
Q1 24
0.2%
3.2%
Cash Conversion
AGL
AGL
MYRG
MYRG
Q4 25
3.14×
Q3 25
2.98×
Q2 25
1.24×
Q1 25
-2.64×
3.57×
Q4 24
1.32×
Q3 24
3.35×
Q2 24
Q1 24
0.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

MYRG
MYRG

Market Type Electrical Construction$442.6M45%
Market Type Transmission$330.3M34%
Market Type Distribution$200.6M21%

Related Comparisons